(A–F) Confocal single-stacks corresponding to the projections shown in Figure 7A–F show (B–B’’’) BRE:d2GFP is activated in the myocardium of ablated hearts at 48 hpt (seven dpf) (n = 21/21), in contrast to (A–A’’’) uninjured controls (n = 0/29). (B’–B’’’) Magnifications of the boxed area in (B) show (B’) co-localization (arrowheads) of BRE:d2GFP and vmhc:mCherry-NTR. However, (D–D’’’) blebbistatin (Blebb) (n = 0/11) or (F–F’’’) DAPT (n = 0/14) treatment inhibits this myocardial BRE:d2GFP injury-induced activation. (A’–F’) merge; (A’’–F’’) Red channel - vmhc:mCherry-NTR; (A’’’–F’’’) Green channel-BRE:d2GFP. V, ventricle; A, atrium. hpt, hours post-MTZ/DMSO treatment.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Elife
Your Input Welcome
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if
additional information is required.
Oops. Something went wrong. Please try again later.